Literature DB >> 27179959

The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer.

Chenglin Zhao1, Ge Gao2, Dong Fang3, Feiyu Li4, Xuedong Yang5, He Wang6, Qun He7, Xiaoying Wang8.   

Abstract

OBJECTIVES: To investigate the efficiency of multiparametric MRI (mpMRI) based on Prostate Imaging Reporting and Data System (PI-RADS) Version 2 (v2) in detecting clinically significant prostate cancer (PCa) and to test the interobserver consistency.
METHODS: Based on PI-RADS v2, two radiologists reviewed the images of 372 patients who underwent prostate biopsy and prebiopsy mpMRI.
RESULTS: There's significant correlation between higher PI-RADS score and the presence of clinical significant PCa (P<.001). PI-RADS score 3 was the best cutoff point with sensitivity and specificity over 80%. The diagnostic concordance was moderate (kappa=0.478).
CONCLUSIONS: PI-RADS v2 demonstrated good accuracy in detecting clinically significant PCa, however the interobserver consistency needs to be improved.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Magnetic resonance imaging; Prostate cancer; Sensitivity; Specificity

Mesh:

Year:  2016        PMID: 27179959     DOI: 10.1016/j.clinimag.2016.04.010

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  25 in total

1.  Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.

Authors:  Matthew D Greer; Anna M Brown; Joanna H Shih; Ronald M Summers; Jamie Marko; Yan Mee Law; Sandeep Sankineni; Arvin K George; Maria J Merino; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  J Magn Reson Imaging       Date:  2016-07-08       Impact factor: 4.813

2.  Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI.

Authors:  Mrishta Brizmohun Appayya; Harbir S Sidhu; Nikolaos Dikaios; Edward W Johnston; Lucy Am Simmons; Alex Freeman; Alexander Ps Kirkham; Hashim U Ahmed; Shonit Punwani
Journal:  Br J Radiol       Date:  2017-12-15       Impact factor: 3.039

Review 3.  A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.

Authors:  Li Zhang; Min Tang; Sipan Chen; Xiaoyan Lei; Xiaoling Zhang; Yi Huan
Journal:  Eur Radiol       Date:  2017-06-27       Impact factor: 5.315

4.  Ruling out clinically significant prostate cancer with negative multi-parametric MRI.

Authors:  Julie Y An; Abhinav Sidana; Sarah A Holzman; Joseph A Baiocco; Sherif Mehralivand; Peter L Choyke; Bradford J Wood; Baris Turkbey; Peter A Pinto
Journal:  Int Urol Nephrol       Date:  2017-11-15       Impact factor: 2.370

5.  Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer.

Authors:  Elmira Hassanzadeh; Francesco Alessandrino; Olutayo I Olubiyi; Daniel I Glazer; Robert V Mulkern; Andriy Fedorov; Clare M Tempany; Fiona M Fennessy
Journal:  Abdom Radiol (NY)       Date:  2018-05

6.  Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks.

Authors:  Yohan Sumathipala; Nathan Lay; Baris Turkbey; Clayton Smith; Peter L Choyke; Ronald M Summers
Journal:  J Med Imaging (Bellingham)       Date:  2018-12-15

7.  Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml?

Authors:  Ning Xu; Yu-Peng Wu; Dong-Ning Chen; Zhi-Bin Ke; Hai Cai; Yong Wei; Qing-Shui Zheng; Jin-Bei Huang; Xiao-Dong Li; Xue-Yi Xue
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-05       Impact factor: 4.553

8.  The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.

Authors:  Stephanie Nougaret; Nicola Robertson; Jennifer Golia Pernicka; Nicolas Molinari; Andreas M Hötker; Behfar Ehdaie; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2017-07

9.  The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy.

Authors:  Jiří Stejskal; Vanda Adamcová; Miroslav Záleský; Vojtěch Novák; Otakar Čapoun; Vojtěch Fiala; Olga Dolejšová; Hana Sedláčková; Štěpán Veselý; Roman Zachoval
Journal:  World J Urol       Date:  2020-08-06       Impact factor: 4.226

10.  Impact of PI-RADS Category 3 lesions on the diagnostic accuracy of MRI for detecting prostate cancer and the prevalence of prostate cancer within each PI-RADS category: A systematic review and meta-analysis.

Authors:  Akshay Wadera; Mostafa Alabousi; Alex Pozdnyakov; Mohammed Kashif Al-Ghita; Ali Jafri; Matthew Df McInnes; Nicola Schieda; Christian B van der Pol; Jean-Paul Salameh; Lucy Samoilov; Kaela Gusenbauer; Abdullah Alabousi
Journal:  Br J Radiol       Date:  2020-10-22       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.